It might be possible to cure hepatitis C in a shorter time, which would also save patients a lot of money.
Using less drugs against hepatitis C is healthier and significantly cheaper for nearly half of the patients, according to a study.
Since hepatitis C patients are often cured before completing a treatment regimen, researchers at Loyola University noted that less of the drugs is needed to fight the disease.
Treatment cost for the average patient would go down by 16 to 20 percent, and as much as 50 percent for 40 percent of the patients.
Dr. Scott Cotler, a professor at Loyola University, pointed out that treatment is currently standardized for a set period of time, not tailored to the patient, according to a report by UPI. Cotler added that in many cases there was a prolonged use of expensive drugs with essentially no additional positive effect.
Read Full Article: Hepatitis C patients found to require lesser drugs for treatment